✨ 5 results found - Searched 22063 records in 4ms.
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_proporsi-gambaran-penyakit-paru-interstisial-pada-pasien-kanker-paru-k-20230801083737.jpg&width=120)
Tesis
Proporsi gambaran penyakit paru interstisial pada pasien kanker paru karsinoma bukan sel kecil dengan terapi epidermal growth factor receptor tyrosine kinase inhibitor di RSUP Persahabatan
2023 | BY Marscha Iradyta Ais - Sita Laksmi Andarini - Dianiati Kusumo Sutoyo - Maryastuti- The proportion of interstial lung disease features in patients with non small cell lung cancer treated with epidermal growth factor receptors tyrosine kinase inhibitor at Persahabatan Hospital.
- Nomor Panggil T23187fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_prevalens-penyakit-paru-obstruksi-kronik-ppok-dan-emfisema-berdasark-20231122110023.jpg&width=120)
Tesis
Prevalens Penyakit Paru Obstruksi Kronik (PPOK) dan Emfisema Berdasarkan Pemeriksaan Spirometri dan Computed Tomography Scanning (CT-scan) Toraks Pada Pasien Kanker Paru di Rumah Sakit Umum Pusat Persahabatan
2019 | BY Prima Belia Fathana - Faisal Yunus - Sita Laksmi Andarini - Aziza G. Icksan- Prevalence of Chronic Obstructive Pulmonary Disease and Emphysema Based on Spirometry and Thorax CT-scan among Lung Cancer Patients Treated at Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T19279fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2FCover.jpg.jpg&width=120)
Tesis
Efikasi dan Toksisiti Erlotinib/Gefitinib sebagai Terapi Lini Kedua Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil
2015 | BY Sita Laksmi Andarini - Jamaluddin M. - Achmad Hudoyo- Efficacy and Toxicity Erlotinib/Gefitinib as Second Line Therapy in Non-Small Cell Lung Cancer Patients.
- Nomor Panggil T 15 543 FK
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_masa-tahan-hidup-pasien-kanker-paru-jenis-karsinoma-jenis-sel-kecil-ya-20231011110923.jpg&width=120)
Tesis
Masa tahan Hidup Pasien Kanker Paru Jenis Karsinoma Jenis Sel Kecil yang Mendapat Monoterapi Dosetaksel sebagai Kemoterapi Lini Kedua dan Faktor Faktor yang Mempengaruhi
2014 | BY Fadlun Bukayer - Anwar Jusuf - Elisna Syahruddin- SURVIVAL RATE OF DOCETAXEL AS SECONDLINE CHEMOTHERAPY FOR NSCLC PATIENTS IN PERSAHABATAN HOSPITAL JAKARTA.
- Nomor Panggil T14334fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_karakteristik-angka-tahan-hidup-dan-faktor-prognostik-pasien-kanker-p-20231011101842.jpg&width=120)
Tesis
Karakteristik, Angka Tahan Hidup dan faktor Prognostik Pasien Kanker Paru Jenis Karsinoma
2014 | BY Ratna Andriani - Elisna Syahruddin - Ahmad Hudoyo- Characteristics, Survival rate and Prognostic Factor of Small Cell Lung Cancer Patients
- Nomor Panggil T14325fk